Ferulic acid ameliorates metabolic dysfunction associated with fatty liver disease by regulating macrophage polarization through spermidine derived from gut microbiota
Journal of Pharmacy and Pharmacology · 2026
DOI: 10.1093/jpp/rgag055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Pingping Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Lin'an Traditional Chinese Medicine Hospital, Affiliated Hospital, Hangzhou City University, Hangzhou 311300, China. Hauptthemen laut MEDLINE: Coumaric Acids, Spermidine, Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
This study aimed to investigate the efficacy and mechanism of Ferulic acid (FA) in a high-fat diet (HFD)-induced murine model of Metabolic dysfunction-associated steatotic liver disease (MASLD), focusing on the gut microbiota-polyamine-macrophage polarization axis.
Methods
A murine MASLD model was induced with an HFD and treated with FA. We evaluated its efficacy through serological and histopathological analyses. Key mechanisms, including macrophage polarization and gut microbiota, were investigated using molecular analyses and 16S rRNA gene sequencing. The direct effect of spermidine on Kupffer cell (KC) polarization was confirmed in vitro. Key findings FA administration attenuated HFD-induced increases in body and liver weight and improved liver pathology. Mechanistically, FA treatment ameliorated gut dysbiosis, increasing beneficial genera like Akkermansia, Enterorhabdus, and Eubacterium xylanophilum, which was associated with elevated serum spermidine. Critically, FA suppressed hepatic KC M1 polarization and enhanced M2 polarization. In vitro experiments confirmed that spermidine directly mediated these immunomodulatory effects.
Conclusions
FA alleviates MASLD by modulating a novel gut microbiota-spermidine-macrophage axis. These findings suggest a new hepatoprotective mechanism for FA and highlight this axis as a potential therapeutic target for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hangzhou Lin'an Traditional Chinese Medicine Hospital, Affiliated Hospital, Hangzhou City University, Hangzhou 311300, China.
- Department of Research and Development, Zhejiang Shangyue Biotechnology Research Center, Hangzhou 310000, China.
Förderung
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Feng, P., Su, H., Wang, W., Bian, Y., Hu, Z., Zhou, K., Wen, C., Chen, Y., Jiang, J., & Ke, S. (2026). Ferulic acid ameliorates metabolic dysfunction associated with fatty liver disease by regulating macrophage polarization through spermidine derived from gut microbiota. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag055
Vancouver
Feng P, Su H, Wang W, Bian Y, Hu Z, Zhou K, et al. Ferulic acid ameliorates metabolic dysfunction associated with fatty liver disease by regulating macrophage polarization through spermidine derived from gut microbiota. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag055
BibTeX
@article{Feng2026,
author = {Feng, Pingping and Su, Hang and Wang, Weifeng and Bian, Yinyan and Hu, Zhixing and Zhou, Kexin and Wen, Chengyong and Chen, Yanqing and Jiang, Jianping and Ke, Songze},
title = {Ferulic acid ameliorates metabolic dysfunction associated with fatty liver disease by regulating macrophage polarization through spermidine derived from gut microbiota},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
doi = {10.1093/jpp/rgag055}
}
EUVIMED